What is Cure Pharmaceutical?
Founded in 2011 and headquartered in Oxnard, California, CURE Pharmaceutical operates as a technology-focused, vertically integrated drug delivery and product development company. Its scope spans both the pharmaceutical and health and wellness industries, positioning it to address a broad spectrum of healthcare needs through innovative product development and delivery systems.
How much funding has Cure Pharmaceutical raised?
Cure Pharmaceutical has raised a total of $19.3M across 5 funding rounds:
Debt
$2M
Debt
$958K
Debt
$6M
Debt
$350K
Share Placement
$10M
Debt (2011): $2M, investors not publicly disclosed
Debt (2012): $958K, investors not publicly disclosed
Debt (2015): $6M, investors not publicly disclosed
Debt (2020): $350K featuring PPP
Share Placement (2020): $10M, investors not publicly disclosed
What's next for Cure Pharmaceutical?
With a major enterprise-level funding context, CURE Pharmaceutical is poised for significant expansion and further product development. The recent strategic investment suggests a focus on scaling operations, enhancing research and development capabilities, and potentially exploring new market opportunities. This infusion of capital will likely accelerate the company's trajectory in bringing advanced drug delivery solutions and health products to market, reinforcing its position as a key player in the health-tech landscape.
See full Cure Pharmaceutical company page
